{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:06:41Z","timestamp":1784185601531,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PRT\/BD\/154463\/2022"],"award-info":[{"award-number":["PRT\/BD\/154463\/2022"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Children living with HIV continue to face high mortality rates in resource-limited settings, especially in sub-Saharan Africa. In Angola, there is a lack of robust data to guide clinical and programmatic strategies targeting this vulnerable population. This study aimed to estimate survival and identify predictors of mortality in children with HIV followed up at a paediatric referral hospital in Angola.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study of children (\u2264\u200915 years) who started ART between 2016 and 2018, with follow-up until 2023. Kaplan\u2013Meier curves and Cox regression models were used to estimate survival and identify factors associated with death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 1,577 person-years of follow-up, a total of 420 deaths occurred, corresponding to a mortality rate of 26.6 deaths per 100 person-years. The median follow-up time was 11.9 months (interquartile range: 3.4\u201338.5). Median survival was significantly lower among children with non-vertical transmission, WHO clinical stage III\/IV, CD4 counts below the age-specific threshold, underweight status, and opportunistic infections. In the multivariable Cox model including transmission route, WHO clinical stage, baseline CD4 count, underweight status, and age group, non-vertical transmission (AHR 1.35, 95% CI 1.11\u20131.65), WHO clinical stage III\/IV (AHR 1.82, 95% CI 1.36\u20132.46), and CD4 below the age-specific threshold (AHR 1.82, 95% CI 1.06\u20133.12) remained independent predictors of mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high mortality observed in this cohort was associated with advanced clinical severity at admission. The finding that non-vertical transmission was independently associated with mortality suggests the need for improved screening and tailored care strategies for children and adolescents infected outside the mother-to-child context. Strengthening early diagnosis and timely initiation of ART is crucial to reducing preventable deaths and achieving global paediatric HIV control targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27747-w","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:05:48Z","timestamp":1778472348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival and mortality predictors among children living with HIV initiating antiretroviral therapy in Angola: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1904-1104","authenticated-orcid":false,"given":"Paulo Ney","family":"Solari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gon\u00e7alo Figueiredo","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"27747_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Global HIV & AIDS statistics \u2014 Fact sheet. Geneva: UNAIDS; 2025. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Also available from (PDF): https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf. Cited 26 May 2025."},{"key":"27747_CR2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). 2024 Global AIDS Update: People Living with HIV \u2013 Thematic Briefing Note. Geneva: UNAIDS; 2024. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024. Cited 26 May 2025."},{"issue":"1","key":"27747_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13052-025-01872-5","volume":"51","author":"GB Mekonnen","year":"2025","unstructured":"Mekonnen GB, Mulatu S, Legesse BT, Messelu MA, Baye FD, Tilaye BA, et al. Incidence of mortality and its predictors among HIV-infected children receiving antiretroviral therapy in Amhara region: a multicenter retrospective follow-up study. Ital J Pediatr. 2025;51(1):68. https:\/\/doi.org\/10.1186\/s13052-025-01872-5.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"27747_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.medmal.2016.07.003","volume":"47","author":"AE Njom Nlend","year":"2017","unstructured":"Njom Nlend AE, Loussikila AB. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy. Med Mal Infect. 2017;47(1):32\u20137. https:\/\/doi.org\/10.1016\/j.medmal.2016.07.003.","journal-title":"Med Mal Infect"},{"key":"27747_CR5","doi-asserted-by":"publisher","first-page":"6409134","DOI":"10.1155\/2018\/6409134","volume":"2018","author":"EA Anigilaje","year":"2018","unstructured":"Anigilaje EA, Aderibigbe SA. Mortality in a cohort of HIV-infected children: a 12-month outcome of antiretroviral therapy in Makurdi, Nigeria. Adv Med. 2018;2018:6409134. https:\/\/doi.org\/10.1155\/2018\/6409134.","journal-title":"Adv Med"},{"issue":"1","key":"27747_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12889-019-6444-7","volume":"19","author":"JN Mutanga","year":"2019","unstructured":"Mutanga JN, Mutembo S, Ezeamama AE, Song X, Fubisha RC, Mutesu-Kapembwa K, et al. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003\u20132015). BMC Public Health. 2019;19(1):115. https:\/\/doi.org\/10.1186\/s12889-019-6444-7.","journal-title":"BMC Public Health"},{"issue":"5","key":"27747_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/QAI.0000000000003090","volume":"91","author":"P Nyakato","year":"2022","unstructured":"Nyakato P, Christ B, Anderegg N, Muhairwe J, Jefferys L, van Dijk J, et al. High unreported mortality in children and youth (<\u200925 years) living with HIV who were lost to care from antiretroviral therapy programs in Southern Africa: results from a multicountry tracing study. J Acquir Immune Defic Syndr. 2022;91(5):429\u201333. https:\/\/doi.org\/10.1097\/QAI.0000000000003090.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"27747_CR8","doi-asserted-by":"publisher","first-page":"102648","DOI":"10.1016\/j.eclinm.2024.102648","volume":"73","author":"A Tagarro","year":"2024","unstructured":"Tagarro A, Dom\u00ednguez-Rodr\u00edguez S, Cotton M, Otwombe K, Klein N, Lain MG, et al. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries. EClinicalMedicine. 2024;73:102648. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102648.","journal-title":"EClinicalMedicine"},{"key":"27747_CR9","unstructured":"Instituto Nacional de Luta contra a SIDA (INLS). National HIV Counselling and Testing Protocol. 5th ed. Luanda: Minist\u00e9rio da Sa\u00fade; 2023. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/protocolo-at-2024-em-revis-o_angola.pdf?sfvrsn=c1a13300_1."},{"key":"27747_CR10","unstructured":"Instituto Nacional de Luta contra a SIDA (INLS). Antiretroviral Treatment Guidelines. Luanda: Minist\u00e9rio da Sa\u00fade; 2024. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/normas-de-tarv-2023_angola.pdf?sfvrsn=27616daf_1."},{"issue":"2","key":"27747_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/pubmed\/fdv046","volume":"38","author":"GF Augusto","year":"2016","unstructured":"Augusto GF. Use of services for prevention of mother-to-child transmission in Angola: a retrospective analysis. J Public Health (Oxf). 2016;38(2):371\u20137. https:\/\/doi.org\/10.1093\/pubmed\/fdv046.","journal-title":"J Public Health (Oxf)"},{"issue":"1","key":"27747_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1186\/s12889-020-09418-6","volume":"20","author":"A Alebel","year":"2020","unstructured":"Alebel A, Engeda EH, Kelkay MM, Petrucka P, Kibret GD, Wagnew F, et al. Mortality rate among HIV-positive children on ART in Northwest Ethiopia: a historical cohort study. BMC Public Health. 2020;20(1):1303. https:\/\/doi.org\/10.1186\/s12889-020-09418-6.","journal-title":"BMC Public Health"},{"issue":"1","key":"27747_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40545-022-00448-6","volume":"15","author":"Y Biyazin","year":"2022","unstructured":"Biyazin Y, Wondwossen K, Wubie AB, Getachew M, Gebremichael B. Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals. J Pharm Policy Pract. 2022;15(1):48. https:\/\/doi.org\/10.1186\/s40545-022-00448-6. https:\/\/joppp.biomedcentral.com\/articles\/.","journal-title":"J Pharm Policy Pract"},{"key":"27747_CR14","unstructured":"World Health Organization Regional Office for Africa. Prevention of mother-to-child transmission \u2013 technical update: implementing the. treat all approach among pregnant and breastfeeding women living with HIV in the WHO African Region. Brazzaville: WHO; 2017. Available from: https:\/\/www.afro.who.int\/sites\/default\/files\/2018-06\/Prevention%20of%20mother-to-child%20transmission%20-%20Technical%20update.pdf."},{"key":"27747_CR15","unstructured":"World Health Organization. WHO Child Growth Standards. Geneva: WHO; 2006. Available from: https:\/\/www.who.int\/tools\/child-growth-standards. Cited 24 Nov 2025."},{"key":"27747_CR16","unstructured":"World Health Organization. Growth reference data for 5\u201319 years. Geneva: WHO; 2007. Available from: https:\/\/www.who.int\/tools\/growth-reference-data-for-5to19-years.\u00a0\u00a0Cited 24 Nov 2025."},{"issue":"5","key":"27747_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/hiv.70015","volume":"26","author":"LS Moshi","year":"2025","unstructured":"Moshi LS, Okuma J, Luoga E, Kalinjuma AV, Mollel GJ, Sigalla G, et al. Trends of severe HIV disease and mortality among children in rural Tanzania. HIV Med. 2025;26(5):800\u201312. https:\/\/doi.org\/10.1111\/hiv.70015.","journal-title":"HIV Med"},{"issue":"7","key":"27747_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/tropicalmed9070154","volume":"9","author":"CE Mashiri","year":"2024","unstructured":"Mashiri CE, Batidzirai JM, Chifurira R, Chinhamu K. Investigating the determinants of mortality before CD4 count recovery in a cohort of patients initiated on antiretroviral therapy in South Africa using a Fine and Gray competing risks model. Trop Med Infect Dis. 2024;9(7):154. https:\/\/doi.org\/10.3390\/tropicalmed9070154.","journal-title":"Trop Med Infect Dis"},{"key":"27747_CR19","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.gpeds.2025.100257","volume":"12","author":"T Tessema","year":"2025","unstructured":"Tessema T, Desalegn M, Abute L, Yohannes T. Determinants of survival of human immune deficiency virus infected children after commencing antiretroviral therapy in Kembata-Tembaro zone: a facility-based retrospective cohort study. Glob Pediatr. 2025;12:100257. https:\/\/doi.org\/10.1016\/j.gpeds.2025.100257.","journal-title":"Glob Pediatr"},{"issue":"1","key":"27747_CR20","doi-asserted-by":"publisher","first-page":"e0314112","DOI":"10.1371\/journal.pone.0314112","volume":"20","author":"G Gurmu","year":"2025","unstructured":"Gurmu G, Merdassa E, Tiruneh G, Efrem K, Belay F, Mekonnen L, et al. Incidence and predictors of mortality among HIV positive children on antiretroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: retrospective cohort study. PLoS ONE. 2025;20(1):e0314112. https:\/\/doi.org\/10.1371\/journal.pone.0314112.","journal-title":"PLoS ONE"},{"issue":"4","key":"27747_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/QAI.0000000000003361","volume":"95","author":"W Nyandiko","year":"2024","unstructured":"Nyandiko W, Enjema NA, Mugo R, Apondi E, Sang E, Mwangi A. Predictors of mortality among children and adolescents living with HIV on antiretroviral therapy in Western Kenya. J Acquir Immune Defic Syndr. 2024;95(4):383\u201391. https:\/\/doi.org\/10.1097\/QAI.0000000000003361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"27747_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/QAI.0000000000003408","volume":"96","author":"S Zhou","year":"2024","unstructured":"Zhou S, Cluver L, Knight L, Edun O, Sherman G, Toska E. Longitudinal trajectories of antiretroviral treatment adherence and associations with durable viral suppression among adolescents living with HIV in South Africa. J Acquir Immune Defic Syndr. 2024;96(2):171\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000003408.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"27747_CR23","doi-asserted-by":"publisher","first-page":"e25215","DOI":"10.1002\/jia2.25215","volume":"21","author":"A Kariminia","year":"2018","unstructured":"Kariminia A, Law M, Davies M, Vinikoor M, Wools-Kaloustian K, Leroy V, et al. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc. 2018;21(12):e25215. https:\/\/doi.org\/10.1002\/jia2.25215.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27747-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:43:38Z","timestamp":1784184218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27747-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27747"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27747-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the National Ethics Committee of the Angolan Ministry of Health (reference: No. 10\/CEMS\/2024). Authorisation was also obtained from the Scientific Directorate of the David Bernardino Paediatric Hospital. Given that the study was based exclusively on anonymised secondary data extracted from routine clinical records, the requirement for individual informed consent was formally waived by the Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2158"}}